This Article contains errors in Figs. 1 and 8 that were introduced during the production process. The compound on the lower right side of Fig. 1 is labelled incorrectly and should be labelled ‘SC83288’. The correct version of Fig. 1 appears below as Fig. 1. In Fig. 8c, ‘SC83458 selected’ should read ‘SC81458 selected’ and in Fig. 8d ‘SC81758’ should read ‘SC81458’. The correct version of Fig. 8 appears below as Fig. 2.
The online version of the original article can be found at 10.1038/ncomms14193
About this article
Cite this article
Pegoraro, S., Duffey, M., Otto, T. et al. Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria. Nat Commun 8, 15273 (2017). https://doi.org/10.1038/ncomms15273
Biological Reviews (2019)